PURE Bioscience, Inc. (OTCMKTS:PURE) Sees Significant Drop in Short Interest

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a large decrease in short interest in November. As of November 30th, there was short interest totalling 400 shares, a decrease of 97.2% from the November 15th total of 14,500 shares. Based on an average daily volume of 46,900 shares, the days-to-cover ratio is currently 0.0 days.

PURE Bioscience Price Performance

PURE stock traded up $0.01 during mid-day trading on Friday, hitting $0.07. The stock had a trading volume of 52,615 shares, compared to its average volume of 29,677. The firm has a fifty day simple moving average of $0.09 and a 200 day simple moving average of $0.08. PURE Bioscience has a 52 week low of $0.06 and a 52 week high of $0.16.

PURE Bioscience (OTCMKTS:PURE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.47 million for the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.